Schmedders, M <br/><br/>
[Benefit assessment by the Federal Joint Committee: assessment of treatment strategies for low risk prostate cancer].  [electronic resource] 

 -  Der Urologe. Ausg. A  Aug 2011 
 - 938-43 p.  digital 
<br/><br/> Publication Type: English Abstract; Journal Article 
<br/><br/><label>ISSN: </label>1433-0563 
<br/><br/><label>Standard No.: </label>10.1007/s00120-011-2545-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Brachytherapy--economics<br/>Cost-Benefit Analysis<br/>Evidence-Based Medicine--economics<br/>Germany<br/>Humans<br/>Male<br/>Middle Aged<br/>National Health Programs--economics<br/>Neoplasm Staging<br/>Prostatectomy--economics<br/>Prostatic Neoplasms--economics<br/>Quality Assurance, Health Care--economics<br/>Radioisotope Teletherapy--economics<br/>Radiotherapy Dosage<br/>Randomized Controlled Trials as Topic<br/>Risk Factors<br/>Survival Rate